1-8 of 8
Debra Bull Linderman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Personalized Oral Maintenance Therapy with Decitabine/Cedazuridine (ASTX727) Combined with a Molecularly Targeted Agent (Venetoclax, Gilteritinib, Ivosidenib, or Enasidenib) in Acute Myeloid Leukemia in First Remission

Alexandre Bazinet, Naval Daver, Farhad Ravandi, Nicholas J. Short, Musa Yilmaz, Maro Ohanian, Jo Ishizawa, Abhishek Maiti, Courtney D. DiNardo, Lucia Masarova, William G. Wierda, Kelly S. Chien, Elias Jabbour, Danielle Hammond, Fadi G. Haddad, Koji Sasaki, Alex Bataller, Debra Bull-Linderman, Gautam Borthakur, Guillermo Garcia-Manero, Hagop M. Kantarjian, Tapan M. Kadia
Journal: Blood
Blood (2024) 144 (Supplement 1): 4277.
https://doi.org/10.1182/blood-2024-198928
Published: 2024
Journal Articles

Phase 2 Study of CPX-351 in Combination with Venetoclax in Patients with Newly Diagnosed, High Risk Acute Myeloid Leukemia

Wei-Ying Jen, Courtney D. DiNardo, Kelly S. Chien, Yesid Alvarado-Valero, Lucia Masarova, Mark Brandt, Debra Bull-Linderman, Naval Daver, Guillermo Montalban-Bravo, Alex Bataller, Guillermo Garcia-Manero, Ghayas C. Issa, Amin Alousi, Nicholas J. Short, Farhad Ravandi, Tapan M. Kadia
Journal: Blood
Blood (2023) 142 (Supplement 1): 4273.
https://doi.org/10.1182/blood-2023-182969
Published: 2023
Journal Articles

Decitabine/Cedazuridine (ASTX727) Combined with a Molecularly-Targeted Agent (Venetoclax, Gilteritinib, Ivosidenib, or Enasidenib) As Personalized Maintenance Therapy in Acute Myeloid Leukemia: First Results from a Phase 1b Study

Alexandre Bazinet, Hagop M. Kantarjian, Farhad Ravandi, Nicholas J. Short, Naval Daver, Maro Ohanian, Musa Yilmaz, Kelly S. Chien, Abhishek Maiti, Courtney D. DiNardo, Jo Ishizawa, Lucia Masarova, Debra Bull-Linderman, Gautam Borthakur, Elias Jabbour, Guillermo Garcia-Manero, Tapan M. Kadia
Journal: Blood
Blood (2023) 142 (Supplement 1): 2909.
https://doi.org/10.1182/blood-2023-172883
Published: 2023
Journal Articles

Azacitidine Plus Venetoclax Maintenance in Acute Myeloid Leukemia Produces Sustained Remissions with Low Toxicity: Results of a Phase 2 Study

Alexandre Bazinet, Hagop M. Kantarjian, Gautam Borthakur, Musa Yilmaz, Prithviraj Bose, Elias Jabbour, Yesid Alvarado Valero, Kelly S. Chien, Naveen Pemmaraju, Koichi Takahashi, Nicholas J. Short, Naval Daver, Ghayas C. Issa, Nitin Jain, Danielle E. Hammond, Debra Bull-Linderman, Courtney D. DiNardo, Jan A. Burger, Alessandra Ferrajoli, Guillermo Montalban-Bravo, Koji Sasaki, Guillermo Garcia-Manero, Farhad Ravandi, Tapan M. Kadia
Journal: Blood
Blood (2023) 142 (Supplement 1): 2884.
https://doi.org/10.1182/blood-2023-172882
Published: 2023
Journal Articles

A Phase II Study of Azacitidine Plus Venetoclax As Maintenance Therapy in Acute Myeloid Leukemia: Durable Responses with Longer Term Follow-up

Alexandre Bazinet, Hagop Kantarjian, Gautam Borthakur, Musa Yilmaz, Prithviraj Bose, Elias Jabbour, Yesid Alvarado, Kelly S. Chien, Naveen Pemmaraju, Koichi Takahashi, Nicholas Short, Naval Daver, Ghayas C. Issa, Nitin Jain, Debra Bull Linderman, Courtney D. DiNardo, Jan A. Burger, Alessandra Ferrajoli, Guillermo Montalban-Bravo, Guillermo Garcia-Manero, Koji Sasaki, Farhad Ravandi, Tapan M. Kadia
Journal: Blood
Blood (2022) 140 (Supplement 1): 9005–9007.
https://doi.org/10.1182/blood-2022-162918
Published: 2022
Journal Articles

A Phase II Study of 5-Azacytidine (AZA) and Venetoclax As Maintenance Therapy in Patients with Acute Myeloid Leukemia (AML) in Remission

Alexandre Bazinet, Hagop Kantarjian, Gautam Borthakur, Musa Yilmaz, Prithviraj Bose, Elias J. Jabbour, Yesid Alvarado, Kelly S. Chien, Naveen Pemmaraju, Koichi Takahashi, Nicholas J. Short, Ghayas C. Issa, Nitin Jain, Alessandra Ferrajoli, Jan A. Burger, Debra Bull Linderman, Naval Daver, Courtney D. DiNardo, Marina Konopleva, Guillermo Garcia-Manero, Koji Sasaki, Farhad Ravandi, Tapan M. Kadia
Journal: Blood
Blood (2021) 138 (Supplement 1): 2326.
https://doi.org/10.1182/blood-2021-150573
Published: 2021
Journal Articles

A Phase I/II Study of Sapacitabine and Venetoclax in Relapsed/Refractory Acute Myeloid Leukemia

Sai Prasad Desikan, Hagop Kantarjian, Courtney D. DiNardo, Gautam Borthakur, Naval Daver, Naveen Pemmaraju, Yesid Alvarado, Jan A. Burger, Debra Bull Linderman, Sherry A. Pierce, Farhad Ravandi, Guillermo Garcia-Manero, Tapan M. Kadia
Journal: Blood
Blood (2021) 138 (Supplement 1): 3419.
https://doi.org/10.1182/blood-2021-151605
Published: 2021
Journal Articles

Inotuzumab Ozogamicin in Combination with Bosutinib for Patients with Relapsed or Refractory Ph+ ALL or CML in Lymphoid Blast Phase

Nitin Jain, MD, Jorge E. Cortes, MD, Farhad Ravandi, MBBS, Marina Konopleva, MD PhD, Yesid Alvarado, MD, Tapan Kadia, MD, William G Wierda, MD PhD, Gautam Borthakur, MD, Kiran Naqvi, MDMPH, Naveen Pemmaraju, MD, Courtney D. DiNardo, MDMSc, Naval Daver, MD, Musa Yilmaz, MD, Keyur Patel, MD PhD, Debra Bull Linderman, RN, Rebecca Garris, Msc, Elias J. Jabbour, MD, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 143.
https://doi.org/10.1182/blood.V130.Suppl_1.143.143
Published: 2017